-
2024-510730-40-00
5
2024-12-12
Hidradenitis Suppurativa
-
2023-509301-80-00
5
2024-11-04
Severe hypertriglyceridemia (SHTG)
-
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
-
2023-509765-20-00
2
2024-10-21
Melanoma: Adjuvant treatment of patients with Stage IIB, IIC, or III m
-
2024-511038-11-00
4
2024-09-24
advanced prostate cancer
-
2023-506334-75-00
5
2024-07-12
Pulmonary Arterial Hypertension
-
2023-508085-15-00
5
2024-05-15
Chronic Obstructive Pulmonary Disease
-
2023-506917-23-00
4
2024-04-19
patients with mild to moderate left-sided ulcerative colitis
-
2023-503655-10-00
5
2023-11-20
Systemic Lupus Erythematosus (SLE).
-
2022-503004-24-00
5
2023-10-20
Influenza virus
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
-
2022-501999-26-00
5
2023-07-12
Severe Hypertriglyceridemia (SHTG)
-
2023-507522-16-00
5
2023-05-22
Metastatic Esophageal or Gastric Cancer
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2023-503501-11-00
5
2023-02-09
Metastatic Non-small Cell Lung Cancer
-
2023-506927-27-00
5
2022-08-29
Children with short stature either born small for gestational age or w
-
2023-508559-37-00
5
2022-07-14
Lupus nephritis
-
2023-505974-14-00
5
2022-06-23
Multiple Sclerosis (MS)
-
2023-504737-41-00
5
2022-06-10
Moderately to Severely Active Crohn's Disease
-
2023-503517-30-00
5
2022-04-01
Extensive-stage small-cell lung cancer
-
2023-506680-34-00
5
2022-03-24
Non-Muscle Invasive Bladder Cancer
-
2024-514618-11-00
5
2022-03-01
Relapsing Multiple Sclerosis